These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 28652007

  • 1. Cytokines affecting CD4+T regulatory cells in transplant tolerance. III. Interleukin-5 (IL-5) promotes survival of alloantigen-specific CD4+ T regulatory cells.
    Hall BM, Plain KM, Tran GT, Verma ND, Robinson CM, Nomura M, Boyd R, Hodgkinson SJ.
    Transpl Immunol; 2017 Aug; 43-44():33-41. PubMed ID: 28652007
    [Abstract] [Full Text] [Related]

  • 2. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
    Plain KM, Verma ND, Tran GT, Nomura M, Boyd R, Robinson CM, Hodgkinson SJ, Hall BM.
    Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
    [Abstract] [Full Text] [Related]

  • 3. Cytokines affecting CD4+T regulatory cells in transplant tolerance. II. Interferon gamma (IFN-γ) promotes survival of alloantigen-specific CD4+T regulatory cells.
    Nomura M, Hodgkinson SJ, Tran GT, Verma ND, Robinson C, Plain KM, Boyd R, Hall BM.
    Transpl Immunol; 2017 Jun; 42():24-33. PubMed ID: 28487237
    [Abstract] [Full Text] [Related]

  • 4. Alloantigen specific T regulatory cells in transplant tolerance.
    Hall BM, Tran G, Hodgkinson SJ.
    Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4+CD25+ Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor.
    Hall BM, Hall RM, Tran GT, Robinson CM, Wilcox PL, Rakesh PK, Wang C, Sharland AF, Verma ND, Hodgkinson SJ.
    Front Immunol; 2021 May; 12():714838. PubMed ID: 34912327
    [Abstract] [Full Text] [Related]

  • 6. Alloactivation of Naïve CD4+CD8-CD25+T Regulatory Cells: Expression of CD8α Identifies Potent Suppressor Cells That Can Promote Transplant Tolerance Induction.
    Verma ND, Robinson CM, Carter N, Wilcox P, Tran GT, Wang C, Sharland A, Nomura M, Plain KM, Bishop GA, Hodgkinson SJ, Hall BM.
    Front Immunol; 2019 May; 10():2397. PubMed ID: 31681288
    [Abstract] [Full Text] [Related]

  • 7. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY, Wang XH, Zhang F, Li XC, Yao AH, Yu Y, Lv L, Li GQ.
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [Abstract] [Full Text] [Related]

  • 8. CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses.
    Verma ND, Plain KM, Nomura M, Tran GT, Robinson C, Boyd R, Hodgkinson SJ, Hall BM.
    Blood; 2009 Jan 08; 113(2):479-87. PubMed ID: 18827184
    [Abstract] [Full Text] [Related]

  • 9. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. V. Dependence of CD4+ suppressor cells on the presence of alloantigen and cytokines, including interleukin 2.
    Pearce NW, Spinelli A, Gurley KE, Hall BM.
    Transplantation; 1993 Feb 08; 55(2):374-80. PubMed ID: 8434390
    [Abstract] [Full Text] [Related]

  • 10. Changes in Reactivity In Vitro of CD4+CD25+ and CD4+CD25- T Cell Subsets in Transplant Tolerance.
    Hall BM, Robinson CM, Plain KM, Verma ND, Tran GT, Nomura M, Carter N, Boyd R, Hodgkinson SJ.
    Front Immunol; 2017 Feb 08; 8():994. PubMed ID: 28878770
    [Abstract] [Full Text] [Related]

  • 11. CD4+CD25+ T Regulatory Cells in Transplantation Tolerance: 25 Years On.
    Hall BM.
    Transplantation; 2016 Dec 08; 100(12):2533-2547. PubMed ID: 27861285
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-12 (IL-12p70) Promotes Induction of Highly Potent Th1-Like CD4(+)CD25(+) T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Recipients.
    Verma ND, Hall BM, Plain KM, Robinson CM, Boyd R, Tran GT, Wang C, Bishop GA, Hodgkinson SJ.
    Front Immunol; 2014 Dec 08; 5():190. PubMed ID: 24847323
    [Abstract] [Full Text] [Related]

  • 13. IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity.
    Tran GT, Hodgkinson SJ, Carter NM, Verma ND, Plain KM, Boyd R, Robinson CM, Nomura M, Killingsworth M, Hall BM.
    Blood; 2012 May 10; 119(19):4441-50. PubMed ID: 22310911
    [Abstract] [Full Text] [Related]

  • 14. Alloantigen-specific CD4(+) regulatory T cells induced in vivo by ultraviolet irradiation after alloantigen immunization require interleukin-10 for their induction and activation, and flexibly mediate bystander immunosuppression of allograft rejection.
    Hori T, Kuribayashi K, Saito K, Wang L, Torii M, Uemoto S, Kato T.
    Transpl Immunol; 2015 Jun 10; 32(3):156-63. PubMed ID: 25861842
    [Abstract] [Full Text] [Related]

  • 15. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.
    Chiffoleau E, Bériou G, Dutartre P, Usal C, Soulillou JP, Cuturi MC.
    J Immunol; 2002 May 15; 168(10):5058-69. PubMed ID: 11994458
    [Abstract] [Full Text] [Related]

  • 16. Abrogation of antibody-mediated allograft rejection by regulatory CD4 T cells with indirect allospecificity.
    Callaghan CJ, Rouhani FJ, Negus MC, Curry AJ, Bolton EM, Bradley JA, Pettigrew GJ.
    J Immunol; 2007 Feb 15; 178(4):2221-8. PubMed ID: 17277127
    [Abstract] [Full Text] [Related]

  • 17. The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or tolerance.
    Nomura M, Plain KM, Verma N, Robinson C, Boyd R, Hodgkinson SJ, Hall BM.
    Transpl Immunol; 2006 Apr 15; 15(4):311-8. PubMed ID: 16635754
    [Abstract] [Full Text] [Related]

  • 18. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
    Plain KM, Boyd R, Verma ND, Robinson CM, Tran GT, Hodgkinson SJ, Hall BM.
    Transplantation; 2007 Mar 27; 83(6):764-73. PubMed ID: 17414711
    [Abstract] [Full Text] [Related]

  • 19. Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.
    Hu H, Zhu X, Joshi S, Lu L, Xia CQ, Patel JM.
    PLoS One; 2015 Mar 27; 10(5):e0124705. PubMed ID: 25933390
    [Abstract] [Full Text] [Related]

  • 20. Transfer of allograft specific tolerance requires CD4+CD25+T cells but not interleukin-4 or transforming growth factor-beta and cannot induce tolerance to linked antigens.
    Hall BM, Plain KM, Verma ND, Tran GT, Boyd R, Robinson CM, Nicolls MR, Berger ME, Nomura M, Hodgkinson SJ.
    Transplantation; 2007 Apr 27; 83(8):1075-84. PubMed ID: 17452898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.